Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-088043

Chief Operating Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2016-01-01 Grant or award +150,000 425,000 D
Derivatives
GIVEN BRUCE D Chief Operating Officer 2016-01-01 Grant or award · Stock Options +60,000 556,000 D
Loading xslF345X03/doc4.xml…